{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T01:15:31Z","timestamp":1763169331630,"version":"3.45.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00520-025-10081-z","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:39Z","timestamp":1761992199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of factors associated with drug fever following gemcitabine and nanoparticle albumin-bound paclitaxel treatment for pancreatic cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Yoshitaka","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Takekuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"key":"10081_CR1","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369:1691\u20131703","journal-title":"N Engl J Med"},{"key":"10081_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00280-016-2972-3","volume":"77","author":"H Ueno","year":"2016","unstructured":"Ueno H, Ikeda M, Ueno M, Mizuno N, Ioka T, Omuro Y et al (2016) Phase I\/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer. Cancer Chemother Pharmacol 77:595\u2013603","journal-title":"Cancer Chemother Pharmacol"},{"key":"10081_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12885-018-5244-2","volume":"19","author":"H Blomstrand","year":"2019","unstructured":"Blomstrand H, Scheibling U, Bratth\u00e4ll C, Green H, Elander NO (2019) Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer. BMC Cancer 19:40","journal-title":"BMC Cancer"},{"key":"10081_CR4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/cncr.22852","volume":"110","author":"KY Bilimoria","year":"2007","unstructured":"Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP et al (2007) Validation of the 6th edition AJCC pancreatic cancer staging system: report from the National Cancer Database. Cancer 110:738\u2013744","journal-title":"Cancer"},{"key":"10081_CR5","first-page":"615","volume":"24","author":"D Ogawara","year":"2016","unstructured":"Ogawara D, Fukuda M, Ueno S, Ohue Y, Takemoto S, Mizoguchi K et al (2016) Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4. Support Care Cancer 24:615\u2013619","journal-title":"Support Care Cancer"},{"key":"10081_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s10147-024-02535-x","volume":"29","author":"H Iihara","year":"2024","unstructured":"Iihara H, Abe M, Wada M, Iino K, Akechi T, Imamura CK et al (2024) 2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis. Int J Clin Oncol 29:873\u2013888","journal-title":"Int J Clin Oncol"},{"key":"10081_CR7","unstructured":"Abraxane\u00ae (nanoparticle albumin-bound paclitaxel) [package insert on the internet]. Tokyo; Taiho pharmaceutical Co., https:\/\/www.info.pmda.go.jp\/go\/pack\/4240409D1023_1_15\/?view=frame&style=XML&lang=ja. accessed October 10, 2025"},{"key":"10081_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1648072","volume":"2019","author":"R Cehreli","year":"2019","unstructured":"Cehreli R, Yavuzsen T, Ates H, Akman T, Ellidokuz H, Oztop I (2019) Can inflammatory and nutritional serum markers predict chemotherapy outcomes and survival in advanced stage nonsmall cell lung cancer patients? BioMed Res Int 2019:1648072","journal-title":"BioMed Res Int"},{"key":"10081_CR9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.lungcan.2011.05.009","volume":"74","author":"I Gioulbasanis","year":"2011","unstructured":"Gioulbasanis I, Georgoulias P, Vlachostergios PJ, Baracos V, Ghosh S, Giannousi Z et al (2011) Mini nutritional assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis. Lung Cancer 74:516\u2013520","journal-title":"Lung Cancer"},{"key":"10081_CR10","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1097\/JTO.0b013e3181da78f9","volume":"5","author":"C O'Dowd","year":"2010","unstructured":"O\u2019Dowd C, McRae LA, McMillan DC, Kirk A, Milroy R (2010) Elevated preoperative C-reactive protein predicts poor cancer specific survival in patients undergoing resection for non-small cell lung cancer. J Thorac Oncol 5:988\u2013992","journal-title":"J Thorac Oncol"},{"key":"10081_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/JTO.0b013e31819578c8","volume":"4","author":"A Koch","year":"2009","unstructured":"Koch A, Fohlin H, S\u00f6renson S (2009) Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy. J Thorac Oncol 4:326\u2013332","journal-title":"J Thorac Oncol"},{"key":"10081_CR12","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1200\/JCO.2011.36.5742","volume":"29","author":"DD Von Hoff","year":"2011","unstructured":"Von Hoff DD, Ramanathan RK, Borad MJ, Laheru DA, Smith LS, Wood TE et al (2011) Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I\/II trial. J Clin Oncol 29:4548\u20134554","journal-title":"J Clin Oncol"},{"key":"10081_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1592\/phco.30.1.57","volume":"30","author":"RA Patel","year":"2010","unstructured":"Patel RA, Gallagher JC (2010) Drug fever. Pharmacotherapy 30:57\u201369","journal-title":"Pharmacotherapy"},{"key":"10081_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.850093","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Wang J, Wang H, Zhang S, Wei Y, Liu S (2022) The interplay between inflammation and stromal components in pancreatic cancer. Front Immunol 13:850093","journal-title":"Front Immunol"},{"key":"10081_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/ijms20030676","volume":"20","author":"A Padoan","year":"2019","unstructured":"Padoan A, Plebani M, Basso D (2019) Inflammation and pancreatic cancer: focus on metabolism, cytokines, and immunity. Int J Mol Sci 20:676","journal-title":"Int J Mol Sci"},{"key":"10081_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097613","volume":"9","author":"W B\u0142ogowski","year":"2014","unstructured":"B\u0142ogowski W, Deskur A, Budkowska M, Sa\u0142ata D, Madej-Michniewicz A, D\u0105bkowski K et al (2014) Selected cytokines in patients with pancreatic cancer: a preliminary report. PLoS ONE 9:e97613","journal-title":"PLoS ONE"},{"key":"10081_CR17","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 395:2008\u20132020","journal-title":"Lancet"},{"key":"10081_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.tjog.2021.07.018","volume":"60","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhao M, Zheng C (2021) Drug fever induced by carboplatin-based regimens: higher incidence in a women\u2019s hospital. Taiwan J Obstet Gynecol 60:882\u2013887","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10081_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7888\/juoeh.43.81","volume":"43","author":"Y Aoyama","year":"2021","unstructured":"Aoyama Y, Ueda T, Kuradome Y, Hoshino K, Harada H, Kinjo Y et al (2021) Hypersensitivity reaction to Carboplatin in gynecologic cancer: a case report and a review of the literature. J UOEH 43:81\u201386","journal-title":"J UOEH"},{"key":"10081_CR20","first-page":"229","volume":"21","author":"B Kneifel","year":"1998","unstructured":"Kneifel B, Brusa-D\u00fcwel P, Becker K, Platz D, Arning M, Kleeberg UR (1998) Oral dexamethasone for the amelioration of the gemcitabine-induced side effects asthenia, edema, and flu-like symptoms. Onkologie 21:229\u2013231","journal-title":"Onkologie"},{"key":"10081_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10096-021-04289-0","volume":"41","author":"A Sokal","year":"2022","unstructured":"Sokal A, Chawki S, Nguyen Y, Sauvanet A, Ponsot P, Maire F et al (2022) Specificities of acute cholangitis in patients with cancer: a retrospective comparative study of 130 episodes. Eur J Clin Microbiol Infect Dis 41:143\u2013146","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-10081-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T01:12:24Z","timestamp":1763169144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-10081-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10081"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-10081-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The requirement of the informed consent from participants was waived by the Ethical Review Board for Life Science and Medical Research of the Hokkaido University Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement of informed consent from participants was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1006"}}